Voglistar - MD 0.2 Tablet
Marketer
Mankind Pharma Ltd
Salt Composition
Voglibose (0.2mg)
Overview Voglistar - MD 0.2 Tablet
DiaBeta-MD 0.2mg tablets manage type 2 diabetes by regulating post-prandial hyperglycemia. This medication is prescribed when dietary modifications and other anti-diabetic therapies prove insufficient to control elevated blood glucose. DiaBeta-MD 0.2mg should be administered immediately prior to meals; dosage and frequency are determined individually by your physician to optimize glycemic control. Discontinuing this medication abruptly is unsafe and may cause dangerously high blood sugar, potentially leading to severe complications such as renal impairment or vision loss. Comprehensive diabetes management includes this medication, alongside a doctor-recommended diet, exercise, and weight management program. Regular blood glucose monitoring is essential. Common side effects include abdominal discomfort, gas, appetite changes, constipation, and diarrhea. Report any persistent or troublesome side effects to your doctor. While DiaBeta-MD 0.2mg alone doesn't induce hypoglycemia, combining it with other diabetes medications (particularly insulin or sulfonylureas) increases this risk. Treat hypoglycemic episodes with plain glucose; table sugar may be ineffective. Inform your doctor of any liver or kidney issues before starting treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., Crohn's disease or ulcerative colitis). Pregnant or breastfeeding individuals should seek medical advice prior to use. Always disclose all medications you are currently taking. Excessive alcohol consumption should be avoided due to the increased risk of hypoglycemia.
Uses of Voglistar - MD 0.2 Tablet
Managing type 2 diabetes
Major Benefits of Voglistar - MD 0.2 Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Avoid contact with the tablets using damp hands. Place the Voglistar-MD 0.2 Tablet in your mouth, but refrain from swallowing until dissolved. It should be consumed on an empty stomach.
Common Side effects of Voglistar - MD 0.2 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglistar - MD 0.2 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Avoid contact with moisture when handling the tablets. Place the tablet in your mouth, but refrain from swallowing immediately. Voglistar - MD 0.2 Tablet should be consumed on an empty stomach.
How Voglistar - MD 0.2 Tablet works:
GlucoControl MD 0.2mg tablets are an antihyperglycemic medication. Their mechanism of action involves the suppression of intestinal enzymes that digest complex carbohydrates into simple sugars like glucose, thus moderating postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglistar - MD 0.2 Tablet and alcohol is unsafe.
PregnancySAFE IF PRESCRIBED
Use of Voglistar-MD 0.2 Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences to fetal development; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Voglistar-MD 0.2 Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Voglistar - MD 0.2 Tablet.
KidneyCAUTION
Patients with severe kidney impairment should use Voglistar-MD 0.2mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Voglistar-MD 0.2mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Voglistar - MD 0.2 Tablet :
Omit any missed Voglistar - MD 0.2 Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglistar - MD 0.2 Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
| Action Class | Alpha-glucosidase inhibitors |





